Aryavan Enterprise Ltd
Incorporated in 1993, Ecofinity Atomix Ltd
is engaged in the business of trading goods.[1]
- Market Cap ₹ 36.8 Cr.
- Current Price ₹ 52.9
- High / Low ₹ 63.7 / 31.6
- Stock P/E 14.3
- Book Value ₹ 43.8
- Dividend Yield 0.94 %
- ROCE %
- ROE 5.10 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Promoter holding is low: 37.8%
- Earnings include an other income of Rs.1.66 Cr.
- Promoter holding has decreased over last 3 years: -26.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Products Iron & Steel Products
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 33.35 | 4.66 | 6.53 | 35.97 | 49.53 | |
| 33.49 | 4.98 | 6.47 | 34.20 | 47.11 | |
| Operating Profit | -0.14 | -0.32 | 0.06 | 1.77 | 2.42 |
| OPM % | -0.42% | -6.87% | 0.92% | 4.92% | 4.89% |
| 0.49 | 0.40 | 0.22 | 0.35 | 1.66 | |
| Interest | 0.08 | 0.00 | 0.00 | 0.04 | 0.16 |
| Depreciation | 0.04 | 0.01 | 0.00 | 0.08 | 0.19 |
| Profit before tax | 0.23 | 0.07 | 0.28 | 2.00 | 3.73 |
| Tax % | 43.48% | 28.57% | 3.57% | 23.50% | |
| 0.13 | 0.06 | 0.27 | 1.53 | 2.77 | |
| EPS in Rs | 0.34 | 0.16 | 0.70 | 2.20 | 3.69 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 451% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 467% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 30% |
| 3 Years: | 29% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|
| Equity Capital | 3.85 | 3.85 | 6.96 | 6.96 |
| Reserves | -0.74 | -0.68 | 23.02 | 23.53 |
| 2.05 | 5.17 | 0.24 | 0.22 | |
| 18.37 | 4.87 | 2.45 | 2.75 | |
| Total Liabilities | 23.53 | 13.21 | 32.67 | 33.46 |
| 0.04 | 0.57 | 12.97 | 12.29 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.44 |
| Investments | 0.00 | 0.58 | 0.07 | 0.08 |
| 23.49 | 12.06 | 19.63 | 20.65 | |
| Total Assets | 23.53 | 13.21 | 32.67 | 33.46 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 0.00 | -4.83 | -7.25 | ||
| 0.00 | 0.68 | -6.16 | ||
| 0.00 | 3.11 | 13.46 | ||
| Net Cash Flow | 0.00 | -1.03 | 0.05 | |
| Free Cash Flow | 0.00 | -5.37 | -7.25 | |
| CFO/OP | 0% | 1,497% | -392% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 151.47 | 516.17 | 93.36 | |
| Inventory Days | 0.00 | 44.89 | ||
| Days Payable | 18.60 | |||
| Cash Conversion Cycle | 151.47 | 516.17 | 119.64 | |
| Working Capital Days | 0.11 | 386.15 | 161.65 | |
| ROCE % | 1.04% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Aug 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Number ・Standalone data |
|
||||||||||
| Approved Solar Plant Capacity KW |
|||||||||||
| Projected Annual Solar Power Generation Lakhs KWH |
|||||||||||
| Subsidiary Ownership Stake (Padmavati Chemicals) Percentage (%) |
|||||||||||
Documents
Announcements
- Closure of Trading Window 2d
-
Board Meeting Outcome for OUTCOME OF BOARD MEETING - ISSUE OF EQUITY WARRANTS
20 Feb - Proposal (20 Feb 2026) to issue 23,90,000 warrants (₹2.39 crore) preferentially; EGM for approval.
-
Board Meeting Intimation for Issue Of Shares.
17 Feb - Board meeting 20 Feb 2026 to consider preferential allotment; trading window closed 18-22 Feb.
-
Result - Financial Results For Quarter Ended 31/12/2025.
14 Feb - Board approved unaudited Q3 and nine-month results ended 31 Dec 2025; standalone net profit Rs84.66L, consolidated Rs81.30L.
-
Board Meeting Outcome for : Outcome Of The Board Meeting Held On Saturday, 14Th February, 2026 And Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Third Quarter And Nine Months Ended On 31St December, 2025
14 Feb - Approved unaudited standalone and consolidated Q3 and nine-month results for period ended 31-Dec-2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
Business Overview:[1]
EAL (Formerly known as Aryavan Enterprise
Limited) is Trader - Wholesaler /Distributor with a 60% Stake in Bulk Drug Intermediate Partnership Firm.